FATE THERAPEUTICS INC — Director's Dealing 2020

Sep 16, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FATE THERAPEUTICS INC (FATE)
CIK: 0001434316
Period of Report: 2020-09-14

Reporting Person: Valamehr Bahram (Chief Development Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-09-14	Common stock	M	3076	$1.69	Acquired	90287	Direct
2020-09-14	Common stock	M	21924	$2.90	Acquired	112211	Direct
2020-09-14	Common stock	S	600	$34.6533	Disposed	111611	Direct
2020-09-14	Common stock	S	16784	$36.0256	Disposed	94827	Direct
2020-09-14	Common stock	S	7016	$36.9277	Disposed	87811	Direct
2020-09-14	Common stock	S	600	$37.49	Disposed	87211	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-09-14	Stock Option (right to buy)	$1.69	M	3076	Disposed	2021-03-11	Common Stock (3076)	Direct
2020-09-14	Stock Option (right to buy)	$2.90	M	21924	Disposed	2026-01-07	Common Stock (21924)	Direct

Footnotes

F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2020.

F2: Represents the weighted average sale price of the shares sold ranging from $34.26 to $35.05 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price.

F3: Represents the weighted average sale price of the shares sold ranging from $35.47 to $36.46 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price.

F4: Represents the weighted average sale price of the shares sold ranging from $36.47 to $37.45 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price.

F5: Represents the weighted average sale price of the shares sold ranging from $37.47 to $37.51 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price.

F6: This option is fully vested.

F7: Not applicable.